Pharming announces commitment to build a new downstream manufacturing facility for RUCONEST®

Leiden, The Netherlands, 18 November 2020: Pharming Group N.V. (Euronext Amsterdam: PHARM) announces it has committed to building a new facility to expand the Company’s downstream processing capacity for its lead product, RUCONEST® (recombinant C1 esterase inhibitor (rhC1INH)). The downstream processing facility will include the purification, filtration and concentration of the starting material. Construction is […]